Mark Pollack to Fear
This is a "connection" page, showing publications Mark Pollack has written about Fear.
Connection Strength
2.254
-
A model of the generation of ataque de nervios: the role of fear of negative affect and fear of arousal symptoms. CNS Neurosci Ther. 2009; 15(3):264-75.
Score: 0.336
-
Orthostatically induced panic attacks among Vietnamese refugees: associated psychopathology, flashbacks, and catastrophic cognitions. Depress Anxiety. 2006; 23(2):113-5.
Score: 0.273
-
Neck-focused panic attacks among Cambodian refugees; a logistic and linear regression analysis. J Anxiety Disord. 2006; 20(2):119-38.
Score: 0.273
-
Changes in anxiety sensitivity with pharmacotherapy for panic disorder. J Psychiatr Res. 2004 Sep-Oct; 38(5):491-5.
Score: 0.249
-
Two weeks of pretreatment with escitalopram facilitates extinction learning in healthy individuals. Hum Psychopharmacol. 2013 Sep; 28(5):447-56.
Score: 0.114
-
D-cycloserine enhancement of fear extinction is specific to successful exposure sessions: evidence from the treatment of height phobia. Biol Psychiatry. 2013 Jun 01; 73(11):1054-8.
Score: 0.111
-
Khy?l attacks: a key idiom of distress among traumatized cambodia refugees. Cult Med Psychiatry. 2010 Jun; 34(2):244-78.
Score: 0.093
-
Long-term management of panic disorder. J Clin Psychiatry. 1990 May; 51 Suppl:11-3; discussion 50-3.
Score: 0.092
-
Efficacy of CBT for benzodiazepine discontinuation in patients with panic disorder: Further evaluation. Behav Res Ther. 2010 Aug; 48(8):720-7.
Score: 0.092
-
Ataque de nervios: relationship to anxiety sensitivity and dissociation predisposition. Depress Anxiety. 2008; 25(6):489-95.
Score: 0.078
-
Prediction of "fear" acquisition in healthy control participants in a de novo fear-conditioning paradigm. Behav Modif. 2007 Jan; 31(1):32-51.
Score: 0.073
-
Clonazepam in the treatment of panic disorder and agoraphobia. Psychopharmacol Bull. 1987; 23(1):141-4.
Score: 0.073
-
Clonazepam in the treatment of panic disorder and agoraphobia: a one-year follow-up. J Clin Psychopharmacol. 1986 Oct; 6(5):302-4.
Score: 0.072
-
Olfactory-triggered panic attacks among Khmer refugees: a contextual approach. Transcult Psychiatry. 2004 Jun; 41(2):155-99.
Score: 0.061
-
What good are positive emotions for treatment? A replication test of whether trait positive emotionality predicts response to exposure therapy for social anxiety disorder. Behav Res Ther. 2023 12; 171:104436.
Score: 0.059
-
Sleep quality and outcome of exposure therapy in adults with social anxiety disorder. Depress Anxiety. 2021 11; 38(11):1182-1190.
Score: 0.050
-
Additional findings on the association between anxiety sensitivity and hypochondriacal concerns: examination of patients with major depression. J Anxiety Disord. 1998 May-Jun; 12(3):225-32.
Score: 0.040
-
D-cycloserine enhancement of exposure therapy for social anxiety disorder depends on the success of exposure sessions. J Psychiatr Res. 2013 Oct; 47(10):1455-61.
Score: 0.029
-
Dehydroepiandrosterone-sulfate/cortisol ratio in panic disorder. Psychiatry Res. 1989 Jun; 28(3):345-50.
Score: 0.022
-
Clonazepam versus alprazolam in the treatment of panic disorder: interim analysis of data from a prospective, double-blind, placebo-controlled trial. J Clin Psychiatry. 1987 Oct; 48 Suppl:16-21.
Score: 0.019
-
On panic attacks and neurologic problems. Am J Psychiatry. 1986 Dec; 143(12):1626-7.
Score: 0.018
-
Augmentation of exposure therapy with D-cycloserine for social anxiety disorder. Arch Gen Psychiatry. 2006 Mar; 63(3):298-304.
Score: 0.017
-
Is panic disorder linked to cognitive avoidance of threatening information? J Anxiety Disord. 1999 Jul-Aug; 13(4):335-48.
Score: 0.011